(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
0.00% $ 33.97
Live Chart Being Loaded With Signals
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide...
Stats | |
---|---|
Объем за сегодня | 5.63M |
Средний объем | 686 607 |
Рыночная капитализация | 1.49B |
EPS | $0 ( 2023-05-04 ) |
Last Dividend | $0.125 ( 2019-02-01 ) |
Next Dividend | $0 ( N/A ) |
P/E | 21.09 |
ATR14 | $0.299 (0.88%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-01-31 | Williams Felicia | Sell | 10 274 | Common Stock |
2023-01-31 | Williams Felicia | Sell | 12 000 | Stock Option (Right to Buy) |
2023-01-31 | Williams Felicia | Sell | 8 740 | Stock Option (Right to Buy) |
2023-01-31 | Williams Felicia | Sell | 17 205 | Stock Option (Right to Buy) |
2023-01-31 | Williams Felicia | Sell | 5 796 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-88.84 |
Last 100 transactions |
Buy: 118 571 | Sell: 1 534 678 |
Объем Корреляция
Meridian Bioscience Inc Корреляция
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Meridian Bioscience Inc Корреляция - Валюта/Сырье
Meridian Bioscience Inc Финансовые показатели
Annual | 2022 |
Выручка: | $333.02M |
Валовая прибыль: | $188.36M (56.56 %) |
EPS: | $0.960 |
FY | 2022 |
Выручка: | $333.02M |
Валовая прибыль: | $188.36M (56.56 %) |
EPS: | $0.960 |
FY | 2021 |
Выручка: | $317.90M |
Валовая прибыль: | $201.15M (63.27 %) |
EPS: | $1.650 |
FY | 2020 |
Выручка: | $253.67M |
Валовая прибыль: | $156.25M (61.60 %) |
EPS: | $1.080 |
Financial Reports:
No articles found.
Meridian Bioscience Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.00678 | 1990-11-29 |
Last Dividend | $0.125 | 2019-02-01 |
Next Dividend | $0 | N/A |
Payout Date | 2019-02-14 | |
Next Payout Date | N/A | |
# dividends | 114 | -- |
Total Paid Out | $9.88 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.53 | -- |
Div. Sustainability Score | 0.950 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.115 | -- |
Year | Amount | Yield |
---|---|---|
1990 | $0 | 0.00% |
1991 | $0 | 0.00% |
1992 | $0 | 0.00% |
1993 | $0 | 0.00% |
1994 | $0 | 0.00% |
1995 | $0 | 0.00% |
1996 | $0 | 0.00% |
1997 | $0 | 0.00% |
1998 | $0 | 0.00% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0.160 | 3.50% |
2004 | $0.178 | 3.83% |
2005 | $0.213 | 2.70% |
2006 | $0.307 | 2.09% |
2007 | $0.434 | 2.63% |
2008 | $0.560 | 1.88% |
2009 | $0.680 | 2.60% |
2010 | $0.760 | 3.51% |
2011 | $0.760 | 3.21% |
2012 | $0.950 | 4.98% |
2013 | $0.570 | 2.75% |
2014 | $0.800 | 3.06% |
2015 | $0.800 | 4.88% |
2016 | $0.800 | 4.10% |
2017 | $0.500 | 2.80% |
2018 | $0.500 | 3.47% |
2019 | $0.125 | 0.74% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.197 | 1.500 | -3.93 | -5.90 | [0 - 0.5] |
returnOnAssetsTTM | -0.0528 | 1.200 | -1.760 | -2.11 | [0 - 0.3] |
returnOnEquityTTM | -0.0681 | 1.500 | -1.867 | -2.80 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.56 | 0.800 | 2.18 | 1.741 | [1 - 3] |
quickRatioTTM | 1.472 | 0.800 | 6.05 | 4.84 | [0.8 - 2.5] |
cashRatioTTM | 0.943 | 1.500 | 5.87 | 8.81 | [0.2 - 2] |
debtRatioTTM | 0.0682 | -1.500 | 8.86 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -65.48 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.00825 | 2.00 | -0.00275 | -0.00550 | [0 - 30] |
freeCashFlowPerShareTTM | -0.148 | 2.00 | -0.0740 | -0.148 | [0 - 20] |
debtEquityRatioTTM | 0.0914 | -1.500 | 9.63 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.534 | 1.000 | 4.43 | 4.43 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.197 | 1.000 | -5.93 | -5.93 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.0116 | 1.000 | -1.176 | -1.176 | [0.2 - 2] |
assetTurnoverTTM | 0.268 | 0.800 | -1.544 | -1.235 | [0.5 - 2] |
Total Score | 0.950 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -61.83 | 1.000 | -6.35 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0681 | 2.50 | -1.200 | -2.80 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.148 | 2.00 | -0.0493 | -0.148 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.00825 | 2.00 | -0.00275 | -0.00550 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.518 | 1.500 | 3.22 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.00295 | 1.000 | -2.57 | 0 | [0.1 - 0.5] |
Total Score | -0.720 |
Meridian Bioscience Inc
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа